Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950103-21-015263
Filing Date
2021-10-01
Accepted
2021-10-01 17:41:59
Documents
2
Period of Report
2021-10-01

Document Format Files

Seq Description Document Type Size
1 dp159010_3-morntazee.html 3  
1 dp159010_3-morntazee.xml 3 1641
2 EXHIBIT 24 dp159010_ex24.htm EX-24 6220
  Complete submission text file 0000950103-21-015263.txt   9202
Mailing Address 2755 CAMPUS DRIVE, SUITE 240 SAN MATEO CA 94403-2538
Business Address
MOMTAZEE JAMES C (Reporting) CIK: 0001209181 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40782 | Film No.: 211300210

Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE, 2 CHURCH STREET HAMILTON HM11 D0 HM11 441-295-5950
Roivant Sciences Ltd. (Issuer) CIK: 0001635088 (see all company filings)

EIN.: 981173944 | State of Incorp.: D0 | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations